Literature DB >> 17460588

Pneumatic displacement of submacular hemorrhage: safety, efficacy, and patient selection.

Mahesh Gopalakrishan1, Anantharaman Giridhar, Savita Bhat, Seshadri Jenardhanan Saikumar, Anna Elias, Sandhya N.   

Abstract

PURPOSE: To investigate the safety and efficacy of pneumatic displacement of submacular hemorrhage without the use of intravitreal tissue plasminogen activator (tPA).
METHODS: In a prospective, consecutive, single-center, noncomparative, interventional case series, 20 consecutive patients with submacular hemorrhage due to various etiologies (duration, 1-30 days; visual acuity, hand movements to 20/125) were treated with intravitreal perfluoropropane gas injection followed by prone positioning for 5 days to 7 days. Patients were observed 1 day, 7 days, 30 days, 3 months, 6 months, and 1 year after the procedure.
RESULTS: Submacular blood was completely or partially displaced from the fovea in 16 of 20 eyes within 7 days after the injection. Mean best-corrected visual acuity improved from 1.6 to 0.72 logarithm of minimum angle of resolution, which was statistically significant (Wilcoxon signed rank test, P = 0.001). Final visual acuity was 20/63 or better in 10 eyes (50%). The change in proportion of eyes with best-corrected visual acuity of 20/63 or better after treatment was statistically significant (McNemar test, P = 0.002). Four patients developed nonresolving vitreous hemorrhage, which necessitated vitrectomy.
CONCLUSION: The results of pneumatic displacement of submacular hemorrhage using perfluoropropane gas are encouraging, thus questioning the role of tPA in the management of such cases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17460588     DOI: 10.1097/01.iae.0000231544.43093.40

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  13 in total

1.  Intravitreal anti-vascular endothelial growth factor monotherapy for large submacular hemorrhage secondary to neovascular age-related macular degeneration.

Authors:  H S Kim; H J Cho; S G Yoo; J H Kim; J I Han; T G Lee; J W Kim
Journal:  Eye (Lond)       Date:  2015-08-14       Impact factor: 3.775

2.  Pneumatic displacement of submacular hemorrhage with or without tissue plasminogen activator.

Authors:  Takeshi Mizutani; Tsutomu Yasukawa; Yuya Ito; Ayae Takase; Yoshio Hirano; Munenori Yoshida; Yuichiro Ogura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-03-29       Impact factor: 3.117

3.  Treatment of massive subretinal hematoma associated with age-related macular degeneration using vitrectomy with intentional giant tear.

Authors:  Eisuke Isizaki; Seita Morishita; Takaki Sato; Masanori Fukumoto; Hiroyuki Suzuki; Teruyo Kida; Mari Ueki; Tsunehiko Ikeda
Journal:  Int Ophthalmol       Date:  2015-07-28       Impact factor: 2.031

4.  Recombinant tissue plasminogen activator, vitrectomy, and gas for recent submacular hemorrhage displacement due to retinal macroaneurysm.

Authors:  Elsbeth J T van Zeeburg; Matteo G Cereda; Jan C van Meurs
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-08-04       Impact factor: 3.117

5.  The effect of initial intravitreal tissue plasminogen activator and gas injection on vision improvement in patients with submacular haemorrhage associated with age-related macular degeneration.

Authors:  Seung Ha Lee; Sang Joon Lee; Yong Il Shin; Hyung Bin Lim; Jung Yeul Kim; Yong Seop Han; Ki Yup Nam
Journal:  Eye (Lond)       Date:  2021-01-09       Impact factor: 4.456

Review 6.  Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA).

Authors:  Ursula Schmidt-Erfurth; Victor Chong; Anat Loewenstein; Michael Larsen; Eric Souied; Reinier Schlingemann; Bora Eldem; Jordi Monés; Gisbert Richard; Francesco Bandello
Journal:  Br J Ophthalmol       Date:  2014-09       Impact factor: 4.638

7.  Tissue plasminogen activator-assisted vitrectomy for submacular hemorrhage due to age-related macular degeneration.

Authors:  Mustafa Gok; V Levent Karabaş; Mehmet S Aslan; Özgür Kara; Süleyman Karaman; Fatih Yenihayat
Journal:  Indian J Ophthalmol       Date:  2017-06       Impact factor: 1.848

8.  Pneumatic displacement and intravitreal bevacizumab: a new approach for management of submacular hemorrhage in choroidal neovascular membrane.

Authors:  Shobhit Chawla; Vishal Misra; Mohit Khemchandani
Journal:  Indian J Ophthalmol       Date:  2009 Mar-Apr       Impact factor: 1.848

9.  Submacular hemorrhage: a study amongst Indian eyes.

Authors:  Ekta Rishi; Lingam Gopal; Pukhraj Rishi; Sabyasachi Sengupta; Tarun Sharma
Journal:  Indian J Ophthalmol       Date:  2012 Nov-Dec       Impact factor: 1.848

Review 10.  Traumatic submacular hemorrhage: available treatment options and synthesis of the literature.

Authors:  Giamberto Casini; Pasquale Loiudice; Martina Menchini; Francesco Sartini; Stefano De Cillà; Michele Figus; Marco Nardi
Journal:  Int J Retina Vitreous       Date:  2019-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.